Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

MRD Ready to Guide Multiple Myeloma Treatment Decisions?

(MedPage Today) -- As minimal residual disease (MRD) testing becomes increasingly important in multiple myeloma care, questions remain about whether MRD negativity should guide decisions on treatment duration and the need for stem cell transplantation...

MRD Ready to Guide Multiple Myeloma Treatment Decisions?

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Monday 16 November →